MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Overview of attention for article published in New England Journal of Medicine, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 36 news outlets
blogs: 6 blogs
policy: 1 policy source
twitter: 243 X users
facebook: 5 Facebook pages

f1000: 1 research highlight platform
video: 1 YouTube creator
guideline: 2 clinical guideline sources
bluesky: 1 Bluesky user
podcasts: 2 podcasts

Readers on

mendeley: 298 Mendeley

So far, Altmetric has seen 6 public wall posts from 5 users.

Centre for Evidence-based Medicine, 16 Jan 2022

https://www.nejm.org/doi/full/10.1056/NEJMoa2100852?query=WB

Centre for Evidence-based Medicine, 04 Jan 2022

https://www.nejm.org/doi/full/10.1056/NEJMoa2100852?query=TOC

MedicoConsult, 08 Sep 2021

Wie erkennt man am sichersten ein Prostatakarzinom (Krebs der Vorsteherdrüse)? Eine hohe Überdiagnoserate (falsch positive…

The Prostate Net, 15 Jul 2021

High rates of overdiagnosis and unnecessary biopsies are the primary reasons that organized prostate cancer screening programs…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 2 additional Facebook posts.